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Abstract
Background—Poor self-rated health (SRH) and elevated inflammation and morbidity and 
mortality are robustly associated in middle- and older-aged adults. Less is known about SRH-
elevated inflammation associations during young adulthood and whether these linkages differ by 
sex.
Methods—Data came from the National Longitudinal Study of Adolescent Health. At Wave IV, 
young adults aged 24–34 reported their SRH, acute and chronic illnesses, and sociodemographic 
and psychological characteristics relevant to health. Trained fieldworkers assessed medication use, 
BMI, waist circumference, and also collected bloodspots from which high-sensitivity CRP (hs-
CRP) was assayed. The sample size for the present analyses was N=13,236.
Results—Descriptive and bivariate analyses revealed a graded association between SRH and hs-
CRP: Lower ratings of SRH were associated with a higher proportion of participants with hs-CRP 
> 3 mg/L and higher mean levels of hs-CRP. Associations between SRH and hs-CRP remained 
significant when acute and chronic illnesses, medication use, and health behaviors were taken into 
account. When BMI was taken into account, the association between SRH and hs-CRP association 
fully attenuated in females; a small, but significant association between SRH and hs-CRP 
remained in males.
Conclusion—Poor SRH and elevated hs-CRP are associated in young adults, adjusting for other 
health status measures, medication use, and health behavior. In males, SRH provided information 
about elevated hs-CRP that was independent of BMI. In females, BMI may be a better surrogate 
indicator of global health and pro-inflammatory influences compared to SRH.
Keywords
self-rated health; C-reactive protein; inflammation; sex differences; young adulthood; 
cardiovascular risk; Add Health
© 2013 Elsevier Inc. All rights reserved.
*Address for Correspondence: University of North Carolina at Chapel Hill, Department of Psychology, CB #3270, Davie Hall, Chapel 
Hill, NC, 27599-3270, lilly_shanahan@unc.edu, phone: (919) 843-6985, fax: (919) 962-2537. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Brain Behav Immun. Author manuscript; available in PMC 2015 February 02.
Published in final edited form as:






















Self-rated health (SRH) measures a person’s subjective, global perception of their health, 
and is often assessed using a single item with a four- or five-point scale (e.g., Jylhä et al., 
2006). Despite criticisms of single-item assessments, SRH is a notably robust predictor of 
future morbidity and mortality in both community-dwelling, generally healthy and also 
patient samples of adults, even with extensive controls for objective indicators of health 
status (e.g., Benjamins et al., 2004; Benyamini and Idler, 1999; DeSalvo et al., 2006; Idler 
and Benyamini, 1997). Several reasons may account for these robust predictions (for recent 
reviews, see Benyamini, 2011; Jylhä, 2009). First, SRH ratings elicit inclusive “summary 
ratings” of health, which likely capture diagnosed diseases, severity and comorbidity of 
conditions, but also self-perceived but not-yet-diagnosable bodily sensations related to 
disease processes. Second, SRH ratings are dynamic, capturing chronic, but also recent or 
intermittent health problems that may otherwise be missed during one-time “objective” 
assessments. Finally, SRH ratings reflect and also influence behavioral (e.g., physical 
activity) and emotional (e.g., depression) factors and also a person’s perceived resources 
(e.g., social support) that may predict later health (Benyamini, 2011; Jylhä, 2009).
Recent research from mostly middle and older adulthood has highlighted pro-inflammatory 
cytokines and their products, including the acute phase reactant C-reactive protein as key 
biological intermediaries in the link between SRH and morbidity and mortality (e.g., 
Christian et al., 2011; Cohen et al., 1997; Janszky et al., 2005; Jylhä et al., 2006; Lekander et 
al., 2004; Tanno et al., 2012; Unden et al., 2007). For example, in a study of generally 
healthy subjects in middle and older adulthood, those with the highest levels of Interleukin-6 
(IL-6) and high-sensitivity C-reactive protein (hs-CRP) also reported the poorest SRH 
(Christian et al., 2011). This association remained significant after accounting for health 
status (e.g., self-reported diseases), health behaviors (e.g., smoking, physical activity and 
other substance use), socioeconomic factors indicative of disease risk (e.g., race, marital 
status), and psychological characteristics that could predispose one to both, poor ratings of 
health and later disease (e.g. depression, neuroticism). Inflammation induces subjective 
feelings of sickness (Dantzer and Kelley, 2007), and it is also a marker of disease risk 
(Ridker, 2007; Shah et al., 2009)—thus, it is a highly plausible biological mechanism in the 
SRH-morbidity/mortality link (e.g., Christian et al., 2011). Indeed, both, elevated 
inflammation—including hs-CRP—and also less than “excellent” or “very good” SRH are 
linked with morbidity and mortality from diabetes, heart disease, stroke, and cancer 
(Benjamins et al., 2004; Benyamini and Idler, 1999; Erlinger et al., 2004; Jylhä, 2009; 
Pearson et al., 2003; Pradhan et al., 2002; Yeh and Willerson, 2003).
Self-Rated Health in Young Adult Males and Females
Less is known about SRH as an indicator of disease risk and its biological manifestations in 
the earlier life course. Young adults are generally viewed as healthy. Nevertheless, SRH 
declines between adolescence and young adulthood (Bauldry et al., 2012), and in recent 
reports, rates of hypertension in US young adults were unexpectedly high (Nguyen et al., 
2011). Indeed, many young adults in the community rate their health as less than “very 
good”—perhaps because they are experiencing subjective feelings of sickness induced by 
physiological changes during the early, “pre-diagnostic” stages of chronic disease (Konsman 
et al., 2002) or because they have received information that they are at high risk for chronic 
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disease. It is during these early stages—before clinical endpoints are reached—when 
interventions to halt or reverse disease progression could be highly beneficial and cost-
effective. Indeed, although elevated inflammatory proteins in the early life course are 
associated with early vascular changes involved in atherosclerosis, these changes may still 
be reversible (e.g., Kapiotis et al., 2006; Reinehr et al., 2006; Wunsch et al., 2006).
When testing SRH-inflammatory marker associations in young adults, potential sex 
differences must be considered. Levels of hs-CRP are almost twice as high in young adult 
females compared to young adult males (Ford et al., 2003; Shanahan et al., 2013), with 26% 
of females as compared to 10% of males meeting the disease-risk cut-off of CRP > 3 mg/L 
(Shanahan et al., 2013). Furthermore, correlates of hs-CRP during young adulthood are 
partially sex-differentiated. Female young adults face a multitude of potentially pro-
inflammatory influences, ranging from actual chronic disease processes to use of oral 
contraceptives and pregnancy-related hormonal/metabolic shifts (Shanahan et al., 2013). In 
turn, male young adults face fewer pro-inflammatory factors, and BMI is less strongly 
associated with hs-CRP in this group.
Here we use a US nationally-representative sample of females and males to test whether 
SRH and levels of systemic inflammation—measured via hs-CRP in this study—are 
associated during young adulthood. Our analyses control for potential confounders of this 
association (reviewed, for example, in Christian et al., 2011; Jylhä, 2009; O'Connor et al., 
2009), including health conditions and medication use, health behaviors, BMI, and also 




Data came from Waves I and IV of the National Longitudinal Study of Adolescent Health 
(Add Health, see Harris et al., 2009). Wave I of Add Health is a nationally representative 
sample of adolescents enrolled in middle school or high school in the US in 1994. The 
National Quality Education Database, which lists all US high schools, provided the 
sampling frame. Eighty high schools were randomly selected out of all high schools with an 
11th grade and at least 30 students enrolled. These 80 high schools were paired with middle 
schools that fed into their student body. Together, 145 schools hosted an in-school survey, 
yielding 90,118 student respondents in grades 7–12 in 1994.
Approximately 200 students from each school were randomly selected for in-depth in-home 
interviews, resulting in N=20,745 (Wave I). The only variables from Wave I used by the 
present analyses are the race/ethnicity variables. Wave IV was collected when respondents 
were 24–34 years old (14 years after Wave I). Of the eligible respondents from Wave I, 93% 
were relocated, 80% were re-interviewed; resulting in 15,701 in-home interviews. Wave IV 
blood samples were obtained at the end of each interview, as described in the Add Health 
documentation of biomarker collection procedures (Harris and Udry, 2013). Dried blood 
spots were mailed to and assayed at the University of Washington Medical Center 
Immunology Lab. Written consent was obtained from young adults at Wave IV.
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C-reactive Protein—An in-depth documentation of the Add Health hs-CRP assay and 
quality control are available online (Whitsel et al., 2013). Briefly, a sandwich ELISA 
method was adapted from a previously published method (McDade et al., 2004). Values 
from dried blood spots and paired plasma samples were highly correlated (r=.98) in a cross-
validation study. Intra-assay variation was 8.1% and inter-assay variation was 11%. In one 
first distinct set of descriptive analyses that established bivariate SRH-CRP associations, we 
divided the CRP continuum into three distinctive groups: low hs-CRP (≤ 3 mg/L; N=7,899, 
60%), elevated hs-CRP (3 to < 10 mg/L; N=3,650, 28%), and very high hs-CRP (≥ 10 mg/L; 
N=1,687, 12% results shown in Figure 1). In all other analyses, including all of the weighted 
logistic regression analyses, we used a continuous, log-transformed variable of hs-CRP that 
included the full range of values. In follow-up analyses, we tested all models using a log-
transformed continuous hs-CRP < 10 mg/L as the outcome variable (results available in 
Supplement 4).
Self-rated health was assessed by asking “In general, how is your health.” Possible 
responses were 5=excellent, 4=very good, 3=good, 2=fair, and 1=poor.
Health conditions were assessed with checklists of recent and chronic health conditions, as 
is common in this type of field-based, epidemiological research. For self-reported diagnoses, 
participants were asked whether a doctor, nurse or other health care provider had ever told 
them that they suffered from a given condition. The subclinical symptoms scale counted 
whether participants reported having had a fever, night sweats, nausea or vomiting or 
diarrhea, blood in stool or in urine, frequent urination, and skin rash or abscess in the past 
two weeks. The infectious/inflammatory diseases scale counted lifetime diagnosis of asthma 
or chronic bronchitis or emphysema, lifetime diagnosis of hepatitis C, and also gum disease, 
active infection, injury, acute illness, surgery, and active seasonal allergies in the past four 
weeks. Other illnesses counted self-reported diagnoses of cancer or lymphoma or leukemia, 
high blood cholesterol or triglycerides or lipids, high blood pressure or hypertension, high 
blood sugar or diabetes, heart disease, migraine headaches, epilepsy or another seizure 
disorder, and HIV/AIDS. Counts > 3 for the three health conditions variables were collapsed 
to a value of “3.” The first two measures were constructed in accordance with the Add 
Health documentation (Whitsel et al., 2013). The other illnesses variable captures the 
remaining health conditions that were assessed.
Medication use was primarily recorded by interviewers from medications/containers 
provided by participants. A minority of participants (22%) recalled their medication use. 
The medication use variable indicated whether respondents were taking (1) NSAID/
Salicylate medication in the past 24 hours, or (2) NSAID/Salicylate medications, (3) Cox-2 
Inhibitor medications, (4) Inhaled Corticosteroid medications, (5) Corticotropin/
Glucocorticoid medications, (6) Antirheumatic/Antipsoriatic medications, and (7) 
Immunosuppressive medications in the past four weeks. This indicator for medication use 
was constructed in accordance with the Add Health documentation (Whitsel et al., 2013).
Health behaviors—Physical activity was calculated as the sum of two items: “In the past 
seven days, how many times did you participate in individual sports such as running, 
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wrestling, swimming, cross-country skiing, cycle racing, or martial arts?” and “In the past 
seven days, how many times did you participate in gymnastics, weight lifting, or strength 
training?” Responses for the individual items were 0=not at all, 1=1 time, 2=2 times, 3=3 
times, 4=4 times, 5=5 times, 6=6 times, and 7=7 or more times. The sum of the two items 
could range from 0 to 14. Drinking behavior was assessed as the extent of drinking in the 
past year. Possible responses included 0= never, 1=1 or 2 days in the past 12 months, 
2=once a month or less, 3=2 or 3 days a month, 4=1 or 2 days a week, 5=3 to 5 days a week, 
and 6=almost every day. The dichotomous current smoking variable indicated whether the 
subject had smoked at least one cigarette/day for the past 30 days. The dichotomous past 
smoking variable indicated whether the subject had ever smoked. The dichotomous insomnia 
variable indicated whether the subject reported difficulties either falling asleep or staying 
asleep on a daily or almost-every-day basis.
Adiposity-related variables were assessed by trained field interviewers. BMI was calculated 
as weight (kg)/height (m2). A squared BMI term was created in order to allow for effects of 
extreme obesity (Ishii et al., 2012). Waist circumference—an additional, and perhaps better 
indicator of health-related adiposity—was measured in centimeters.
Demographic variables—Dummy variables coded different racial/ethnic groups 
assessed at Wave 1 of the study: White, Black, Asian, American Indian, Hispanic, and other. 
Participants who indicated being Hispanic were coded into this category regardless of 
whether they indicated any other racial category. Young adults reported their marital status. 
Educational attainment was assessed on an 11-point scale (1=less than 8th grade to 
11=doctoral degree).
Psychological characteristics—Depressive symptoms were measured with four 
indicators from the Center for Epidemiologic Studies Depression Scale (CES-D) items with 
adequade Cronbach’s as described by Peirreira (2005). Items included “could not shake off 
the blues,” “felt depressed,” “felt happy,” and “felt sad” in the past week. Neuroticism was 
assessed using Mini- International Personality Item Pool (IPIP) items, and consisted of the 
simple sum with appropriate reverse coding, with Cronbach’s α=.62 in the Add Health study 
(Baldasaro et al., 2013; Donnellan et al., 2006).
Finally, females reported whether they were currently pregnant or taking oral 
contraceptives. Table 1 shows the means and standard deviations or N and weighted % for 
all study variables. Supplement 1 also shows the prevalence of each level of each illness 
variable.
Analytic Strategy
We estimated six nested regression models predicting hs-CRP with SRH and increasingly 
stringent sets of controls. Model 1 included only self-rated health as a main effect. Model 2 
entered the main effect of sex. Model 3 added the interaction between sex and SRH, which 
tested whether SRH-CRP associations differed in males and females. Model 4 added the 
health conditions and medication use variables as main effects. Model 5 added health 
behaviors (physical activity, drinking, current smoking, past smoking) as main effects. 
Finally, Model 6 added measures of health-related adiposity (BMI, BMI2, and waist 
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circumference) as main effects, and also a BMI by sex interaction considering that BMI-
CRP associations may differ in young adult females and males (Shanahan et al., 2013). All 
models were weighted and adjusted the standard errors of the coefficients for the sample 
design of Add Health. Sensitivity analyses tested whether the SRH findings from Model 6 
would remain the same when adjusting for age and sociodemographic (race, marital status, 
education levels), psychological (depressive symptoms, neuroticism) factors, insomnia, and 
also when using hs-CRP < 10 mg/L only.
The analysis sample consisted of cases with valid sample weights (N=14,800), non-missing 
for hs-CRP (N=13,247), and non-missing for sex and race (N=13,236). We constructed 5 
complete data sets via multiple imputation with chained equations to address the small 
amount of missing data in the remaining covariates. We also conducted all analyses using 
listwise deletion and obtained the same substantive pattern of results.
Results
Descriptive Statistics and Bivariate Models
Table 2 shows that approximately 56% of young adults in the analytic sample rated their 
health as “very good” or above; the remainder rated their health as “good” or below. 
Percentages in each category of SRH were similar for males and females. Figure 1 shows 
the percentage of people with low (< 3 mg/L), elevated (3 to < 10 mg/L), and very high (≥10 
mg/L) hs-CRP for each category of self-rated health. Associations between SRH and 
elevated hs-CRP were graded: As ratings of self-rated health decreased from excellent to 
poor, the percentage of subjects with hs-CRP < 3 mg/L also decreased and the percentage of 
subjects with hs-CRP ≥ 3 mg/L increased. Notably, the shape of the associations between 
SRH and CRP 3 to < 10 mg/L, and SRH and CRP ≥ 10 mg/L were remarkably similar. 
Therefore, and also because evidence is accumulating that cases with CRP > 10 score 
highest on many indicators of chronic diseases risk (e.g., Ishii et al., 2012), cases with hs-
CRP ≥ 10 mg/L were included in all subsequent analyses. All subsequent analyses use the 
log-transformed hs-CRP variable as the outcome.
Bivariate Associations
Figure 2 shows bivariate associations between self-rated health and the continuous logCRP 
variable in the overall sample, males, and females (b=0.28, p=0.000; b=0.29, p=0.000; 
b=0.25, p=0.000, respectively). Figure 2 further illustrates the graded bivariate association 
between SRH and hs-CRP, and also shows that, consistent with other work on young adults 
(Shanahan, 2013; Ford, 2003), hs-CRP levels were significantly higher in females than in 
males.
Multivariate Models
Next, we tested nested regression models with increasingly stringent controls in the 
prediction of hs-CRP (described above). We began with Model 0, which tested bivariate 
associations. Results showed that, with the exception of smoking status, all variables were 
bivariately associated with hs-CRP. In Model 1 (main effect of SRH), poorer SRH ratings 
were associated with higher levels of hs-CRP. In Model 2 (main effect of sex), female sex 
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predicted higher hs-CRP. In Model 3 (SRH by sex interaction), the SRH by sex interaction 
was not significant. In Model 4 (illness/medication use), higher numbers of subclinical 
symptoms, other diseases, and medication use were associated with higher hs-CRP. 
Importantly, even after accounting for these measures of health status and medication use, 
SRH independently contributed to the prediction of hs-CRP. In fact, the reduction of the size 
of the SRH coefficient with the inclusion of these health status and medication variables was 
negligible.
In Model 5 (health behaviors), physical activity and alcohol use were associated with lower 
levels of hs-CRP. Finally, in Model 6 (BMI/health-related adiposity), all indicators of 
health-related adiposity (BMI, BMI2, and waist circumference) were associated with hs-
CRP, as was the BMI by sex interaction. Young adults with high BMI and high waist 
circumference were more likely to have higher levels of hs-CRP. BMI was also more 
strongly associated with hs- CRP in females (b=0.18, p < .001) than in males (b=0.10, p < .
001). Importantly, once these variables were entered into the model, the SRH by sex 
interaction became significant, but the main effect of SRH was much smaller. The R2 of this 
final model was .30. Supplement 2 shows all models for males and females separately, 
revealing that the inclusion of BMI-related variables completely attenuated SRH-CRP 
associations in females (b=-.02, p=0.32), but not in males (b=.06, p=.01). Supplement 2 also 
shows that BMI was more strongly associated with hs-CRP in females than in males.
Sensitivity analyses were conducted in order to test the robustness of the sex by SRH 
interaction observed in Model 6. This interaction remained significant when 1) adjusting for 
age, and sociodemographic (race, marital status, education level) factors, psychological 
(neuroticism, depressive symptoms) factors, and also insomnia (see Supplement 3 for 
results), 2) deleting cases with hs-CRP ≥ 10 mg/L (see Supplement 4 for results), 3) deleting 
cases that reported ≥1 acute condition (e.g., fever, night sweats, vomiting etc.), 4) deleting 
cases that reported ≥2 acute conditions, 5) adjusting for variables that coded pregnancy and 
use of oral contraceptives and/or deleting females who endorsed these variables, 6) testing 
interactions between sex and the other health variables and also medication use (which were 
non-significant), and 7) testing interactions between SRH and obesity in the prediction of 
hs-CRP (which were non-significant).
We also tested whether entering BMI alone (without additional adiposity-related terms) 
would result in the emergence of the SRH by sex interaction—and this was the case. Finally, 
in an effort to better understand the SRH by sex interaction, we tested whether the BMI-
SRH association was stronger in females than in males. SRH and BMI were correlated at r=.
32, p<.001 in females and r=.29, p<.001 in males, but these correlations were not 
significantly different in size.
Assessing the size of the self-rated health effect in males
In order to gauge the effect size of the SRH-CRP association in Model 6 for males, we 
calculated standardized coefficients for SRH and other health conditions. Betas were at 0.05 
for SRH, 0.11 for subclinical symptoms, and 0.06 for medication use. Thus, the size of the 
SRH-CRP association in males was relatively small, but comparable to that of associations 
between both subclinical symptoms and medication use with hs-CRP.
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Subjective perceptions of the body’s functioning—including SRH—are associated with 
inflammatory markers even after adjusting for health behaviors, chronic disease risk 
indicators and/or measures of actual chronic or other illness in samples of mostly middle and 
older adults (e.g., Christian et al., 2011; Cohen et al., 1997; Jylhä et al., 2006; Lekander et 
al., 2004; Tanno et al., 2012; Unden et al., 2007). Although many young adults have not yet 
been diagnosed with chronic illness, almost half of the young adults in the nationally 
representative sample studied here rated their health as less than “very good,” and we tested 
whether SRH is associated with elevated hs-CRP during young adulthood and whether these 
linkages differ by sex.
Bivariate results identified graded SRH-CRP associations. As subjective ratings of health 
declined, the proportion of individuals with hs-CRP > 3 mg/L and mean levels of hs-CRP 
increased—even when health conditions, medication use, health behaviors and 
psychological dispositions (in the sensitivity analyses) had been taken into account. 
Research on SRH has argued that subjective ratings reflect, in part, subtle bodily feelings 
that would be missed by health checklists or other “objective” health assessments (Christian 
et al., 2011; Craig, 2002; Jylhä et al., 2006). It is possible that SRH ratings, in part, capture 
such subtle aspects of health during young adulthood.
BMI and Sex Differentiated SRH-CRP Associations in Young Adults
Fundamental changes in the SRH-CRP association were observed when measures of health-
related adiposity, assessed by trained interviewers, were taken into account. In both females 
and males, the size of the SRH-CRP association decreased with the inclusion of BMI. In 
females, the SRH-CRP coefficient was fully attenuated; in males, independent associations 
between SRH and hs-CRP remained. What could explain this sex-difference in attenuation?
In young adult females, BMI may be a more powerful “surrogate” or summary measure of 
pro-inflammatory influences than in males. BMI is typically a better indicator of pro-
inflammatory body fat in young adult females than in males (Gallagher et al., 1996; 
Wozniak et al., 2009); this notion was supported by our finding that BMI was more closely 
associated with hs-CRP in females than in males. Furthermore, BMI in young adult females 
could capture additional pro-inflammatory conditions, including childbirth and pregnancy-
related physical and metabolic changes (Stuebe and Rich-Edwards, 2009)—that would not 
necessarily be reflected in subjective health ratings.
In males, SRH-CRP associations remained significant even after the inclusion of BMI. One 
simple question assessing subjective perceptions of health could uniquely contribute to 
identifying young adult males at increased risk for morbidity/mortality from chronic disease. 
BMI may not be an ideal surrogate indicator of health in young males, because it could 
reflect high amounts of body fat but also of lean muscle mass (Gallagher et al., 1996). To 
address this concern, we had also included waist circumference as a predictor of hs-CRP, 
but this measure also did not fully attenuate SRH-CRP associations. Nevertheless, the size 
of the SRH-CRP association in males’ final multivariate models was relatively small, and 
Figure 1 also suggests that the specificity of prediction is not high. Both SRH and hs-CRP 
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are global, systemic, nonspecific indicators. That is, SRH could be rated as less than “very 
good” for a multitude of reasons. Similarly, the actual physiological origins of elevated 
systemic inflammatory proteins could be wide-ranging. Thus, perhaps it would be unrealistic 
to expect large associations between these two relatively global indicators of perceived and 
biologically manifested health.
Our sex-differentiated findings are consistent with several studies and reviews reporting 
greater SRH-mortality associations in males than females (Benjamins et al., 2004; 
Benyamini and Idler, 1999; Hays et al., 1996; Idler and Benyamini, 1997). Indeed, one study 
reported that among individuals with less than “very good” self-rated health, men were more 
likely to die from cancer and also heart disease than women (Benjamins et al., 2004)—and 
both of these conditions are also associated with elevated hs-CRP (e.g., Ko et al., 2012; 
Ridker, 2007; Shah et al., 2009).
We should also note, however, that our sex-differentiated findings were inconsistent with 
some studies from middle and older adulthood that reported that SRH-inflammatory marker 
associations were present in females even after accounting for health-related adiposity 
(Janszky et al., 2005; Unden et al., 2007), or that these association were stronger in females 
than in males (Lekander et al., 2004; Tanno et al., 2012). Jylhä (2009) proposed that sex 
differences in associations between SRH and its correlates and outcomes could change with 
age. It is plausible, for example, that young adult males face fewer “competing” pro-
inflammatory influences compared to older males—who experience decreasing levels of 
testosterone, more central adiposity, and also clinical stages of chronic disease (Eskes and 
Haanen, 2007; Kelly and Jones, 2013; Laughlin et al., 2008; Pugh et al., 2000). In turn, as 
we detailed above, young adult females in their reproductive years face a variety of pro-
inflammatory factors (Shanahan et al., 2013), but fewer during at least some parts of older 
adulthood, before they reach clinical endpoints of chronic disease (Eskes and Haanen, 2007; 
Pérez-López et al., 2010). Thus, the SRH-CRP signal may be most “noisy” for older adult 
males and young adult females, contributing to changing sex differences in this association 
across the life course.
Limitations
First, this study was cross-sectional, with only one assessment of hs-CRP. Therefore, we 
could not test whether decreases in self-rated health predicted increases in systemic 
inflammation or vice versa. Second, although the Add Health study has quite extensive 
health and medication assessments considering its field-based, large-scale nature, the health 
status measures were nevertheless self-reported. Future research should also assess 
physician-verified diagnoses when possible. Third, the Add Health study currently has data 
on one inflammatory marker only. Previous studies with older samples had also reported 
associations between SRH with other markers of immune function, including IL-6 (Christian 
et al., 2011), TNF-alpha, IL-1 (Lekander et al., 2004), and white blood cell counts (Jylhä et 
al., 2006). These additional biomarkers also should be tested in younger samples.
Despite these limitations the Add Health data presented a rare opportunity to test SRH-
hsCRP associations in a nationally representative sample of young adults. Our bivariate 
Shanahan et al. Page 9






















analyses showed that assessing this non-invasive one-item measure could be a simple first 
step in identifying both females and males at risk for heightened systemic inflammatory 
processes. Especially in young males, SRH may be a useful independent indicator of disease 
risk even beyond BMI.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Self-rated health is associated with elevated C-reactive protein (CRP) in young 
adulthood, and it uniquely contributes to explaining elevated CRP levels in males.
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Weighted proportion of cases in low (< 3 mg/L), elevated (3 to < 10 mg/L), and very high (≥ 
10mg/L) hs-CRP categories across levels of self-rated health.
E = Excellent, VG = Very Good, G = Good, A = Average, P = Poor
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Weighted mean levels of log hs-CRP for the overall sample, male sample, and female 
sample across levels of self-rated health.
E = Excellent, VG = Very Good, G = Good, A = Average, P = Poor
Note: Log hs-CRP includes hs-CRP ≥ 10 mg/L cases.
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